The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury.
Katerelos M, Gleich K, Harley G, Loh K, Oakhill JS, Kemp BE, de Souza DP, Narayana VK, Coughlan MT, Laskowski A, Ling NXY, Murray-Segal L, Brink R, Lee M, Power DA, Mount PF.
Katerelos M, et al. Among authors: kemp be.
Biomed Pharmacother. 2024 Jun;175:116730. doi: 10.1016/j.biopha.2024.116730. Epub 2024 May 14.
Biomed Pharmacother. 2024.
PMID: 38749175
Free article.